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Attachment of HIV to macrophages is a critical early event in the establishment of infection. In the present study, we
demonstrate the involvement of integrin v3 (vitronectin receptor) in HIV infection of peripheral blood monocyte-derived
macrophages. Culturing monocytes in the presence of M-CSF for 3 days upregulated expression of the v-containing
integrins, v3 and v5. The increase in v3 expression was accompanied by increased HIV-1 replication by monocytes.
Immunoblot analysis showed that purified HIV-gp120 protein interacted with CD4 and v3 in immunoprecipitation exper-
iments. Neutralizing antibodies against the v3 integrin interfered with the coprecipitation of v3 with an anti-gp120
antibody and substantially inhibited HIV infection of monocytes. Neutralizing antibodies against v5 or 1 integrins did not
significantly affect HIV infection. These results indicate that HIV infection of primary monocytes requires differentiation of
these cells and may involve v3 interaction with the HIV-1 envelope protein gp120 for productive infection. © 2002 Elsevierrin; vitrINTRODUCTION
Binding of HIV to the plasma membrane of cells is the
first step in a series of events by which the viral genome
is introduced into the cell during infection. The interac-
tion of HIV with its cellular receptor is thought to result in
alterations in the conformation of the receptor that are
required for viral entry. Identification of cellular receptors
for HIV has been of particular interest, since this is an
important target for clinical therapy and could be used to
prevent viral infection and spreading. CD4 has been
identified as a primary receptor for HIV and binds tightly
to the HIV envelope glycoprotein, gp120 (1, 2). This bind-
ing alters the conformation of gp120, but viral binding
and these conformational changes are not sufficient for
HIV infection of cells (3, 4). Therefore, other factors are
likely involved in HIV infection.
Monocyte/macrophages play a major role in HIV trans-
mission and throughout all stages of HIV infection and
disease (5, 6). For example, HIV transmission may re-
quire transfer of infected monocytes, and long-lived tis-
sue macrophages may provide a source of viral particles
and act as a reservoir of HIV. Human monocyte-derived
1 To whom correspondence and reprint requests should be ad-
dressed at Northeastern Ontario Regional Cancer Centre, 41 Ramsey31macrophages are susceptible to in vitro infection by
monocytotrophic HIV (5–8). However, several studies
have demonstrated that freshly isolated monocytes are
difficult to infect with HIV and that successful viral infec-
tion occurs only after the cells are allowed to differenti-
ate by culture for several days in the presence of human
serum, growth factors, or cytokines (9–11).
In the present study, we have examined the possible
involvement of integrin adhesion receptors in HIV infec-
tion. Integrins are utilized during infection of host cells by
a variety of intracellular parasites or viruses (12–15). HIV
infection of primary monocytes requires that the mono-
cytes be prepared by culturing in suspension or under
adherent conditions in the presence of M-CSF for at least
3 days (9–11). These conditions also result in the upregu-
lated expression of monocyte v-containing integrins
(16–18), and these changes in integrin expression have
been previously shown to be required for monocyte in-
fection with adenovirus-derived vectors (19). Therefore,
we have analyzed the role of the v-containing integrins,
v3 and v5, in HIV-1 infection of primary monocyte-
derived macrophages.
RESULTS
Expression of various integrins on monocyte surface
Primary monocytes were cultured on tissue cultureScience (USA)
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tions and examined for the expression of multiple inte-
grin subunit mRNAs by Northern blot analysis. Freshly
isolated monocytes did not express the v, 3, and 5
integrin subunits. However, expression of these integrin
subunits rose markedly after 3 days of culture and be-
came more prominent in cells cultured for longer dura-
tions (Fig. 1A). In contrast, the 1 integrin subunit was
constitutively expressed through 5 days in culture. The
expression of integrin adhesion molecules on the sur-
face of the monocytes was measured by fluorescence
flow cytometry using specific anti-integrin antibodies.
The v and v3 integrins were not expressed on the
surface of primary monocytes, but were expressed on
the surface of monocytes that were cultured on tissue
culture substrates in the presence of M-CSF for 3 and 5
days (Fig. 1B). The 1 integrins were expressed on
primary monocytes to a similar extent as on monocytes
precultured on tissue culture substrates. Therefore, the
expression of certain monocyte integrins was upregu-
lated by culture on adherent substrates in the presence
of M-CSF. In particular, the expression of the 3 and v
integrin subunits were strongly upregulated following
3–5 days of culture under conditions typically required
for HIV infectivity.
Time course of HIV-1 infection is coincident with v
expression
Primary human monocytes cultured on tissue culture
plastic substrates in the presence of M-CSF for various
durations were infected with HIVBa-L. Infection was deter-
mined by measuring the amount of HIV-gag-pol mRNA
present by RT-PCR followed by Southern blot analysis or
by detection of HIV-p24 in culture supernatants by ELISA
assay. HIV mRNA was not detected in monocytes cul-
tured for only 1 day prior to inoculation with virus, sug-
gesting that these cells could not be infected by HIV (Fig.
2A). HIV gag-pol mRNA was detected in monocytes that
had been precultured for 3 days prior to HIV infection and
became more prominent in cells precultured for longer
durations. The quality of the amplified cDNA was tested
and normalized by measuring the amount GAPDH deter-
mined by PCR of the cDNA (Fig. 2B). HIV infection was
also examined by measuring HIV-p24 in the culture me-
dia of monocytes cultured on plastic substrates in the
absence or presence of M-CSF (Fig. 3). Monocytes
treated with M-CSF were infected to a much greater
extent than untreated monocytes, although culturing the
cells on plastic substrates for more than 3 days did
enhance HIV infection compared to fresh monocytes.
FIG. 2. HIV-1 gag-pol amplimer of RNA from the monocytes infected
at various times in culture. (A) RNA (1 g) purified from monocytes
cultured for various durations and then infected with HIV was subjected
to RT-PCR with oligonucleotides that amplify HIV-gag-pol or GAPDH
and then detected by Southern blot analysis with HIV-gag-pol or
GAPDH-specific oligonucleotide probes. (B) Densitometric analysis of
the HIV-gag-pol-hybridizing signal normalized for GAPDH.
FIG. 1. (A) Expression of integrin mRNA in cultured monocytes.
Primary monocytes cultured on culture substrates in the presence of
M-CSF for 1, 2, 3, or 5 days were harvested and the RNA was purified.
RNA (10 g) was subjected to Northern blot analysis with probes that
recognize v, 1, 3, and 5 integrin subunits. (B) Cell surface expres-
sion of monocyte integrin adhesion molecules. Primary monocytes or
monocytes cultured on culture substrates for 1, 3, or 5 days were
harvested and fixed in 1% paraformaldehyde and then incubated with
the indicated anti-integrin antibodies for 30 min at 4°C. The cells were
washed and incubated with an FITC-conjugated secondary antibody
for 30 min. The cells were then fixed in 1% paraformaldehyde and the
fluorescence profiles were determined by FACS analysis. The fluores-
cence profiles of nonimmune IgG (open curve) and antibody-stained
cells are shown (closed curve).
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Therefore, monocytes cultured on adherent tissue cul-
ture plastic substrates for more than 3 days in the ab-
sence or presence of M-CSF could be infected with HIV.
Inhibition of HIV-1 infection by anti-v3 integrin
antibody
The correlation between the time course of monocyte
culture required for both HIV infectivity and v3 expres-
sion suggests that v3 may serve as a cofactor for HIV
infection. To test this hypothesis, we infected monocytes
cultured on adherent substrates with HIV in the presence
of blocking anti-integrin antibodies and then measured
HIV-gag-pol mRNA levels 24 h postinfection or HIV-p24
antigen in culture supernatants 6 days postinfection. The
amount of GAPDH cDNA was also determined by PCR of
the same samples to normalize RNA amounts. These
studies show that the inclusion of anti-v3 polyclonal
antibodies or inclusion of a neutralizing monoclonal an-
tibody markedly inhibited the production of HIV gag-pol
mRNA by approximately 70% relative to the GAPDH con-
trol (Fig. 4A). Similarly, inclusion of an anti-v3, neutral-
izing antibody blocked HIV-p24 production by approxi-
mately 40–45% (Table 1). Inclusion of the anti-v3 anti-
bodies did not promote detectable cell retraction or cell
loss from the monocyte monolayer and antibody-treated
and untreated monolayers had indistinguishable mor-
phologies (data not shown). However, in contrast to the
inhibition by anti-v3 antibodies, neutralizing anti-v5
monoclonal antibody only marginally inhibited HIV infec-
tion. Inclusion of neutralizing antibodies against the
21 or 51 integrins had no effect on HIV infection
as measured by the production of HIV gag-pol mRNA
(Fig. 4B).
HIV-1 gp120 interacts with v3 integrin
The correlation between cell surface v3 expression
and the ability of HIV-gp120 to bind the monocyte surface
was determined by blot analysis with streptavidin-HRP.
The monocytes were cultured for 1, 3, and 5 days in the
presence or absence of M-CSF. Biotin-labeled gp120
was bound to and chemically crosslinked to the mono-
cytes cell surface and the amount of bound gp120 de-
termined by blotting with streptavidin-HRP. Monocytes
cultured on tissue culture substrates in the presence or
absence of M-CSF for at least 3 days bound gp120 (Fig.
5A). Monocytes treated with M-CSF bound greater
amounts of gp120 than untreated cells, and binding was
enhanced by increased durations of treatment. For de-
tection of cell surface v3 or 1 expression, monocytes
cultured in the presence or absence of M-CSF were
surface-labeled by incubation with NHS-biotin, and cell
lysates were normalized for biotin-labeled proteins, im-
munoprecipitated with anti-v3 or anti-1 antibodies,
and then subjected to blot analysis with streptavidin-
HRP. Monocytes cultured in the absence or presence of
M-CSF showed an enhanced expression of v3 that
directly correlated with the increase in gp120 binding to
the monocyte surface. The cell surface expression of the
1 integrin did not change significantly during this time
in culture.
FIG. 4. Effect of anti-integrin antibodies on HIV infection of cultured
monocytes. Monocytes were cultured for 5 days in the presence of
M-CSF. The cells were then incubated with HIVBa-L in the presence or
absence of the indicated anti-integrin antibodies. The monolayers were
washed and grown in culture media prior to the isolation of RNA. (A)
RNA (1 g) was subjected to RT-PCR with oligonucleotides that amplify
HIV gag-pol or GAPDH and then assayed by Southern blot analysis
with HIV gag-pol or GAPDH-specific oligonucleotide probes. (B) Den-
sitometric analysis of the HIV gag-pol-hybridizing signal normalized for
GAPDH. The data are representative of three separate determinations.
FIG. 3. HIV-p24 levels in the media of monocytes infected with HIV.
Monocytes were cultured on culture substrates in the absence or
presence of M-CSF for 1, 2, 3, 5, or 7 days and infected with HIVBa-L
(m.o.i.  0.05). The cells were then incubated in culture media. Culture
supernatants were harvested on Day 7 postinoculation and then as-
sayed for cell-free HIV-p24 antigen by ELISA using NEN/DuPont p24
ELISA test kits.
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To determine whether gp120 and CD4 specifically in-
teract with v3, monocytes cultured in the presence of
M-CSF for 5 days were incubated with, and chemically
crosslinked to, biotin-labeled gp120. Cell lysates were
immunoprecipitated with specific anti-integrin antibodies
and the immunoprecipitated material was subjected to
blot analysis with streptavidin-HRP. The results of these
experiments showed that gp120 coprecipitated with an-
tibodies that recognize v3 but not with the anti-2, 5,
or 1 antibodies (Fig. 5B). Immunoprecipitation of gp120-
crosslinked monocytes also showed that gp120 could be
coprecipitated with anti-gp120, anti-v3, and anti-CD4
antibodies, (but not anti-1 integrin antibodies), indicat-
ing involvement of v3 in a CD4-mediated interaction
with HIV-gp120 (Fig. 5C). It should be noted that CD4
expression was not significantly enhanced following
treatment of the monocytes with M-CSF for 3 days (data
not shown). Further, competitive inhibition by preincuba-
tion of monocytes with unlabeled gp120, anti-CD4, or
anti-v3 antibodies each substantially reduced the
binding of biotinylated gp120 to the monocyte cell sur-
face while anti-1 antibodies did not. These experiments
suggest that v3 is present in a complex that includes
CD4 and HIV-gp120 and further suggest that v3 is a
cofactor that promotes interaction between CD4 and HIV.
DISCUSSION
In the present study, we have shown that culturing
primary monocytes in M-CSF upregulates v3 expres-
sion and that v3 can be an important component in
HIV infection of monocytes in vitro.
Monocytes and macrophages serve a variety of immu-
noregulatory, phagocytic, and secretory functions. HIV
infection of monocytes/macrophages can alter crucial
immunoregulatory functions including monocyte/endo-
thelial cell interactions, cytokine production, and acces-
TABLE 1
Effect of Anti-v Integrin Antibodies on p24 Antigen Production
by HIV-Infected Monocytes
Antibody
p24 production
Experiment 1 Experiment 2
% Production % Inhibition % Production % Inhibition
None
(Control) 100 0 100 0
v3 53 19 47* 61  11 39*
v5 81 22 19 130 —
Note. Monocytes were cultured for 5 days in the presence of M-CSF.
The indicated antibodies were incubated with the cells at 4°C for 1 h,
and then the cells were inoculated with HIVBa-L in the presence of
antibodies. After 1 h, cells were washed with medium containing
antibodies and replaced with antibody-containing medium for 6 days.
Viral p24 levels in culture supernatants were determined by the NEN/
DuPont p24 ELISA test kit. Data in both experiments are presented as
the mean  standard deviation relative to the control for at least three
determinations and differences were determined using a Student’s t
test.
* P  0.05.
FIG. 5. Levels of monocyte-bound HIV gp120, v3, or 1 integrins.
(A) Monocytes cultured in the presence or absence of M-CSF were
surface-biotinylated or incubated with biotin-labeled gp120 at the indi-
cated times and then immunoprecipitated with anti-gp120, anti-v3, or
anti-1 antibodies. The immunoprecipitates were then subjected to
blot analysis by incubation in 1:2000 streptavidin-horseperoxidase
(HRP) conjugate in 0.5% BSA in TBST. The HRP was detected by
incubation in Supersignal reagent and exposed to Hyperfilm-ECL X-ray
film. (B) Specificity of HIV-gp120 interactions with integrin adhesion
receptors in cultured monocytes. Monocytes cultured in the presence
of M-CSF for 5 days were incubated with biotin-labeled gp120 and then
treated with the DTSSP crosslinker. The cells were lysed and the
lysates immunoprecipitated with the indicated anti-integrin antibodies
and goat-anti-mouse IgG Sepharose. The crosslinker was cleaved by
incubation in DTT and the immunoprecipitate subjected to blot analysis
with streptavidin-HRP. HRP was detected by incubation in Supersignal
reagent and exposed to X-ray film. (C) Coprecipitation of HIV gp120 with
anti-CD4 or anti-v3 antibodies. (Panel a) Monocyte surface proteins
were labeled by incubation with biotin-labeled gp120, crosslinked, and
immunoprecipitated with anti-1 (control), anti-gp120, anti-CD4, or anti-
v3 antibodies. (Panel b) Monocytes were pretreated with unlabeled
gp120, anti-CD4, anti-v3, or anti-1 (control) antibodies, as indicated,
prior to incubation and crosslinking with biotin-labeled gp120. The cell
lysates were immunoprecipitated with anti-gp120 and biotin-labeled
gp120 was detected as described above.
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sory cell function (20–22). The complex interactions be-
tween monocyte/macrophages and HIV are of special
importance, since these cells are relatively refractory to
the cytopathic effects of HIV and probably serve as a
major reservoir for the virus as well as a vehicle for
disseminating HIV to various tissues (5, 23, 24). There-
fore, inhibition of monocyte/macrophage infection by HIV
and determination of factors required for viral entry are
important for designing clinical strategies to inhibit HIV
infection and progression of the disease.
HIV has been shown to involve several coreceptors in
addition to CD4 for entry into target cells. The exact
mechanism by which these coreceptors contribute to
HIV entry remains unclear. In the past few years, remark-
able progress has been made in identifying chemokine
receptors as critical components in HIV infection of a
number of cell types and cell lines. Chemokine receptors
are large molecules belonging to the family of seven-
transmembrane spanning GTP-binding proteins (25).
Binding of HIV strains which are tropic for T-cells to
various target cells is mediated by the CXC chemokine
receptor 4 (CXCR4), or fusion (26). Binding of macro-
phage-tropic HIV to target cells is mediated by the CC
chemokine receptor 5 (CCR5) and can be competitively
blocked by treatment with -chemokines or chemokine
analogs (14, 27–31). A number of studies have shown
that chemokine receptors are coreceptors for HIV and
that blocking these coreceptors on various immune cells
can have strong antiviral effects (12, 13). In addition, it
has been shown that culturing monocytes under condi-
tions which promote differentiation, such as treatment
with M-CSF, can also induce CCR-5 expression, suggest-
ing CCR5 may be involved in mediating HIV infection in
differentiated cultured monocytes (10, 33). One study (33)
has shown that a derivative of RANTES, which can block
binding via CCR5, can inhibit HIV infection of PHA-
treated macrophages in vitro; however, other studies
have shown that RANTES requires interactions with cell
surface proteoglycans, not present on M-CSF monocyte-
derived macrophages, in order to be inhibitory (34, 35).
Further, a number of studies have shown that HIV infec-
tion of primary monocytes or macrophage-derived mono-
cytes is not inhibited by inclusion of chemokines even
though CCR5 is expressed on these cells (36–38). There-
fore, it seems likely that HIV infection of monocytes and
monocyte-derived macrophages may involve other mol-
ecules in addition to or distinct from CCR5.
Integrin adhesion receptors, in particular v-
containing integrins, have been shown to mediate
binding and internalization of a variety of intracellular
parasites and viruses (12–15, 19). Whether these re-
ceptors could be possible candidates for mediating
HIV binding and internalization is not known. Recent
studies have demonstrated, and we confirmed in the
present study, that v3 and v5 integrin receptors
are expressed on the monocyte surface after 3 days in
culture with M-CSF (16–18). We hypothesized that the
initial absence of these receptors might account for
the fact that productive HIV infection of freshly isolated
primary monocytes is difficult; infection also requires
that monocytes be cultured for several days especially
in the presence of M-CSF (9–11). However, we have
also showed that culturing primary monocytes on tis-
sue culture substrates without cytokines for longer
that 3 days is also sufficient to upregulate HIV infec-
tion. This is likely due to the observation that adherent
monocytes are able to synthesize and secrete cyto-
kines such as IL-1, TNF-, and M-CSF (39, 40). The
time course required for HIV infection correlated with
the expression of the v-containing integrins in par-
ticular the expression of the v3 integrin. Further,
different culture conditions also showed a direct cor-
relation between HIV infectivity of monocytes and up-
regulation of the v3 integrin expression. In addition,
inclusion of a specific anti-v3 monoclonal antibody,
that is known to block ligand binding (41), partially
inhibited HIV infection of cultured monocytes as de-
tected both by the presence of the HIV-gag-pol mRNA
and secretion of the HIV-p24 antigen. These results
support the notion that HIV infection of monocytes is
mediated at least in part by the v3 integrin. The
anti-v3 antibody inhibited the amount of HIV-gag-
pol mRNA detected the day following infection by
approximately 70% while the anti-v3 antibody inhib-
ited HIV-p24 secretion detected 6 days after infection
by approximately 40%. This difference is likely due to
the release of virus by the HIV-infected monocytes and
reinfection of neighboring cells during the 6 days in
culture. In these experiments, the antibodies were
added during and immediately after the original inoc-
ulation and proteolysis and phagocytosis are expected
to decrease their ability to effectively inhibit ligand/
monocyte binding over time. Although it is also possi-
ble that these differences could be related to signals
induced by anti-v3 integrin antibodies that inhibit
HIV replication, the anti-v3 antibodies have been
shown to directly block interactions with HIV-gp120
which correlates with their effects on HIV infection.
Finally, the coimmunoprecipitation experiments re-
vealed that HIV-gp120 binds to cell surface v3 and
is part of a complex that includes CD4. M-CSF treat-
ment does not change CD4 expression to a large
enough extent to account for the changes in HIV in-
fection or complex formation as described previously
(31, 33, 42). Further, the anti-v3 antibodies block the
interaction between v3 and gp120, suggesting that
these antibodies are able to inhibit interactions be-
tween HIV and monocytes. These results suggest a
possible mechanism by which v3 could support HIV
infection by enhancing interactions of the virus with
the monocyte and thereby promoting internalization.
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MATERIALS AND METHODS
Monocyte isolation
Monocytes were isolated from the peripheral blood
mononuclear cells of donors seronegative for HIV and
hepatitis after leukapheresis and purification by counter-
current centrifugal elutriation (43).
Detection of cell surface integrins expressed on
monocytes
Monocytes (106) cultured in the presence of M-CSF
were harvested at selected times and fixed in 1% para-
formaldehyde, washed twice in PBS, and resuspended in
FACS binding buffer (PBS containing 2% FBS, 1% BSA,
and 0.1% NaN3) (44). Cells were incubated with mono-
clonal antibodies against v (LM142, Chemicon Interna-
tional, Temecula, CA) (41), v3 (LM609), 5 (mAb16), or
1 (mAb13) (45) at 4°C for 45 min and washed 3 times
with binding buffer. The washed cells were incubated
with a sheep anti-mouse IgG-FITC or sheep anti-rat IgG-
FITC-conjugated secondary antibody (Life Technology,
Burlington, ON) at 4°C for 30 min. Monocytes were
washed 3 times with PBS, fixed with 1% paraformalde-
hyde, and analyzed for fluorescence on an EpicsElite
fluorescence cytometer (Coulter Corporation, Burlington,
ON).
RNA isolation and Northern blot analysis of integrin
mRNA
Monocytes (107) cultured in the presence of rM-CSF
were harvested at 1, 3, and 5 days in a guanidium
isothiocyanate solution and were extracted with phenol-
chloroform to isolate total RNA as previously described
(46). Total RNA (10 g) was subjected to electrophoresis
on 1% agarose gels containing formaldehyde. The RNA
was transferred to Nytran Plus membranes (Schleicher
and Scheull, Mandel Scientific Co., Mississauga, ON) by
capillary diffusion with 20 SSPE. Individual cDNA
probes against the 1, 3, 5, and v integrin subunits
were labeled with [32P]dCTP (New England Nuclear,
Mandel Scientific Co.) using a random primer labeling kit
(Stratagene, La Jolla, CA). Hybridizations were carried
out at 42°C in 50% formamide, 5 SSPE, 5 Denhardt’s
solution, 0.5% SDS, and 100 g/ml salmon sperm DNA
(47). The blots were washed once with 4 SSPE, 0.1%
SDS at room temperature for 30 min followed by 30 min
washes in 0.5 SSPE, 0.1% SDS at 42°C and at 55°C.
The blots were then exposed to Hyperfilm-MP (Amer-
sham, Oakville, ON) at 80°C.
HIV-1 infection of monocytes
Primary monocytes or monocytes cultured for 1, 2, 3, or
5 days in the presence or absence of M-CSF were
washed, incubated in macrophage-SFM media (Life
Technology, Gaithersbury, MD), and exposed to HIV-1Ba-L,
a monocytotrophic HIV strain (Advanced Biotechnologies
Inc., Columbia, MD), at a multiplicity of infection of 0.05
infectious virus particles/target cell (7). After a period of
2 h to allow viral adsorption, cultures were washed with
medium and harvested after 24 h for RT-PCR analysis.
Alternately, infected monocytes were grown in culture for
6 days, and then culture supernatants were assayed for
HIV-p24 using the NEN/Dupont ELISA analysis kit, ac-
cording to the manufacturer’s instructions (7). For some
experiments, HIV infection was carried out in the pres-
ence of 10 g/ml of anti-integrin monoclonal antibodies
against 21 (clone P1E6, Life Technologies), 5
(mAb16), 1 (mAb13), v (LM142), v3 (LM609), v5
(P1F6), or with anti-vitronectin receptor polyclonal anti-
bodies at a titer of 1:1000.
RT-PCR for gag-pol HIV transcripts
Monocytes were cultured in the presence of M-CSF for
1, 2, 3, or 5 days, infected with 0.05 HIV-1Ba-L particles/
target cell in the presence or absence of different anti-
integrin antibodies and cultured for 24 h. Total RNA was
isolated and 1 g was reverse-transcribed using 10 ng of
an oligo(dT)12–18 primer, 10 units of Moloney murine leu-
kemia virus-reverse transcriptase (MMLV-RT; Life Tech-
nologies), in 1 PCR buffer, and 1 mM dNTPs, in a total
volume of 20 l at 42°C for 60 min (48, 49). The mixture
was inactivated at 94°C for 10 min, and 10 l of the cDNA
was then amplified by PCR to detect HIV gag-pol or
GAPDH using 100 pmol of each of the appropriate primer
pairs, 1 mM dNTPs, and 5 U Taq DNA polymerase (Life
Technologies). The cycle program consisted of an initial
denaturation step at 94°C, followed by 30 cycles of 1 min
at 94°C, 1 min at 55°C, and 2 min at 72°C. The samples
were subjected to electrophoresis on 2% agarose-Tris-
buffered EDTA (TBE) gels and transferred to 0.22 m
nitrocellulose filters (Schleicher and Scheull). The result-
ing blots were then probed with appropriate end-labeled
oligonucleotide probes that recognize HIV gag-pol, or
GAPDH, washed, and exposed to Hyperfilm-MP X-ray
film (49). Electronic images of the resulting X-rays were
captured using a VideoMaster VDS gel documentation
system (Pharmacia Biotechnology, Baie d’Urfe, QU) and
the densities of the HIV gag-pol hybridizing bands deter-
mined and normalized for the densities of the corre-
sponding GAPDH-hybridizing bands.
Biotinylated-gp120 crosslinking and integrin
immunoprecipitation
Monocytes, cultured for 1, 3, or 5 days, were incubated
for 1 h at 4°C with 50 M biotin-labeled gp120 (Advanced
Biotechnologies Inc.). The gp120 was crosslinked to
monocytes using 3,3-dithiobis(sulfosuccinimidyl propio-
nate) (DTSSP) as recommended by the supplier (Pierce
Chemical Co., Rockford, IL). For some experiments, the
monocytes were surface-labeled by incubation in 100
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g/ml biotin-NHS (Pierce Chemical Co.) in PBS for 30
min. The monocytes were harvested and then lysed in
150 mM octylglucoside, 150 mM NaCl, 10 mM HEPES,
pH 7.4, 1 mM CaCl2, and 1 mM MgCl2. The lysates were
immunoprecipitated with anti-integrin antibodies (1 g)
against v3 (LM609), v (LM142), 1 (mAb13), or 5
(mAb16) overnight at 4°C and then incubated with 25 l
of 10% protein A-Sepharose (Pharmacia) for 2 h (47). For
coprecipitation experiments, monocytes crosslinked to
biotinylated gp120 were immunoprecipitated with anti-
bodies against gp120 (Advanced Biotechnologies Inc.),
CD4 (Becton Dickenson, Mississauga, ON), or v3. The
beads were washed twice with PBS containing 0.1%
Triton X-100 and 1 mg/ml bovine serum albumin and
twice with PBS. The beads were then boiled for 5 min in
SDS treatment buffer containing 5 mM DTT (to cleave the
crosslinker) and subjected to electrophoresis on 7.5%
polyacrylamide gels containing SDS. The gels were elec-
trophoretically transferred to nitrocellulose filters (Schlei-
cher and Schuell), blocked by incubation in 3% BSA in
Tris-buffered saline containing 0.1% Tween-20 (TBST),
and incubated for 2 h in 1:2000 streptavidin-horseradish
peroxidase (HRP) conjugate (Amersham) in 0.5% BSA in
TBST. The filters were washed 3 times with TBST, and the
HRP was detected by incubation in Supersignal reagent
(Pierce Chemical Co.) and exposed to Hyperfilm-ECL
X-ray film (Amersham).
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